Institut Bordet - Retour à la page d'accueil

Philippe Lewalle

Department : Experimental Haematology Laboratory
 
philippe.lewalle [at] bordet.be

Publications

Sweet's syndrome induced by pegfilgrastim during a myelodysplastic syndrome AREB2: A case report.

Authors : Nelis S, Azerad MA, Drowart A, Lewalle P, Efira A
Year : 2019
Journal : Rev Med Interne

Prophylaxis of infections post-allogeneic transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Authors : Lewalle P, Pochon C, Michallet M, Turlure P, Brissot E, Paillard C, Puyade M, Roth-Guepin G, Yakoub-Agha I, Chantepie S
Year : 2019
Journal : Bull Cancer

Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD.

Authors : Socié G, Milpied N, Yakoub-Agha I, Bay JO, Fürst S, Bilger K, Suarez F, Michallet M, Lewalle P, Liens D, Mathis C, Guemas E, Vernant JP
Year : 2019
Journal : Blood Adv

Human CD8<sup>+</sup> CD25 <sup>+</sup> CD127 <sup>low</sup> regulatory T cells: microRNA signature and impact on TGF-ß and IL-10 expression.

Authors : Rouas R, Merimi M, Najar M, Zein NE, Fayyad-Kazan M, Berehab M, Agha D, Bron D, Burny A, Rachidi W, Badran B, Lewalle P, Fayyad-Kazan H
Year : 2019
Journal : J Cell Physiol

Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium.

Authors : Devos T, Verhoef G, Steel E, Mazure D, Lewalle P, Bron D, Berneman Z, Benghiat FS, Mineur P, Theunissen K, Zachée P, Doyen C, Put N, Lejeune M, Van Eygen K, Havelange V, Reusens M, Pluymers W, Peeters K
Year : 2019
Journal : Acta Haematol

More publications »

Follow us!

Youtube

Exclusive images of the new Jules Bordet Institute!

Watch the video and discover the major project for the new Jules Bordet Institute. Magnificent images of the construction work on the   80,000 m² dedicated exclusively to cancer are accompanied by explanations on how the project was conceived to combine excellence of patient care with optimal well-being for patients and care staff.

Support research

Support research

Research at the Institut Jules Bordet depends on your generosity. Make a donation today and join us in the fight against cancer.

Learn more